Khalil Choucair/LinkedIn
Jan 19, 2025, 14:12
Khalil Choucair: Potential biomarkers of IO-therapy in patients of extremes of age
Khalil Choucair, Chief Fellow of Hematology & Oncology at Karmanos Cancer Institute, reshared a post by BMJ Oncology on LinkedIn, adding:
“Our work exploring potential biomarkers of IO-therapy in patients of extremes of age, is now published in BMJ Oncology.”
Quoting BMJ Oncology‘s post:
“Participation of older patients in immune checkpoint inhibitors trials has been suboptimal, particularly at the extremes of age.”
Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinoma.
Authors: Khalil Choucair, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 15:06
Feb 21, 2025, 14:27
Feb 21, 2025, 14:13
Feb 21, 2025, 13:29